In our previous studies, we found that SERPINB2, also called plasminogen activator inhibitor 2 (PAI-2), could serve as an effective marker for predicting toxicity in response to multiple hazardous substances in both cord blood-derived stem cells21 and various types of cancer stem cells47. This evidence concerns the gene SERPINB2 and cancer.